BioCardia (BCDA) Preferred Shares (2015)
BioCardia's (BCDA) quarterly Preferred Shares came in at $46.0 million in Q4 2015.
Powered by 
Analysis
BioCardia (BCDA) Preferred Shares (2015) Analysis & Trends
BioCardia (BCDA) has reported Preferred Shares for 1 consecutive years, with $46.0 million the latest figure, recorded in Q4 2015.
- On a quarterly basis, Preferred Shares changed N/A year-over-year to $46.0 million in Q4 2015; TTM through Dec 2015 was $46.0 million, a N/A change from a year earlier, with the FY2015 full-year figure at $46.0 million, changed N/A from the prior year.
- Preferred Shares was $46.0 million for Q4 2015 at BioCardia.
- Over five years, Preferred Shares peaked at $46.0 million in Q4 2015 and troughed at $46.0 million in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 2,000.00 |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | - |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | - |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | - |